HealthXWire Awards R&R Medicinals Best New Product of 2024 for Topical Pain Relief
HealthXWire has honored R&R Medicinals, a provider of CBD products, with the Best New Product of 2024 for Topical Pain…
Category: Medication Monitor
Hajj 2024: International SOS encourages organisations to prioritise pilgrim health and safety with new precautions
The annual Hajj pilgrimage, a global gathering attracting over 1.8 million participants last year1, is expected to take place in…
4 best health supplements to promote overall wellness
Now forget the basic healthcare routine – Introducing cutting-edge supplements designed to support your overall health from within. Starting from…
Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer
Hyundai Bioscience announced on April 25th that its clinical development plan of oral “Niclosamide Metabolic Anticancer Drug” targeting cancer patients with intractable…
Tetra Pharm Technologies and Glysious Announce Collaboration to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery…
Pharmactive Presents Affron® Saffron Gummies and Aged Black Garlic
Catering to the world of natural wellness, Pharmactive Biotech Products, SLU will showcase two premier clean-label botanical ingredients: affron® saffron…
TreeFrog Presents Data from Its Parkinson’s Cell Therapy Program
TreeFrog Therapeutics, a cell therapy development company with its leading Parkinson’s disease program, is presenting for the first time at…
Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor – Pimicotinib
9 April 2024 (Beijing Time), Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics) announced the completion of patient enrollment for its pivotal Phase III…
Transcenta Announces Collaboration with Agilent to Develop a Claudin18.2 Companion Diagnostic to Support Osemitamab (TST001) Global Phase III Trial
Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing…
Marengo Therapeutics Announces First Drug Candidate Nomination from Oncology Collaboration with Ipsen
Marengo Therapeutics, Inc, a clinical-stage biotech company pioneering a new way to activate T cells that target the Vβ chain…